Status:
COMPLETED
Ancillary Study to Protocol 20060104
Lead Sponsor:
Amgen
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
Ancillary study to the Etanercept protocol 20060104. Subjects have been asked to provide additional blood samples for further assessment.
Eligibility Criteria
Inclusion
- Signed informed Consent Meet all inclusion critieria outlined in Amgen Protocol 20060104
Exclusion
- Meet exclusion criteria outlined in Amgen Protocol 20060104
Key Trial Info
Start Date :
December 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2007
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00439894
Start Date
December 1 2006
End Date
October 1 2007
Last Update
March 21 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.